NEW YORK (GenomeWeb News) – Personalis said after the close of the market Thursday that it has gained an exclusive license to commercialize the Pharmacogenomics Knowledge Base (PharmGKB) and has launched its genome services for researchers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.